• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎:临床医生的实验室诊断。一篇更新文章。

COVID-19: laboratory diagnosis for clinicians. An updating article.

作者信息

Vieira Luisane Maria Falci, Emery Eduardo, Andriolo Adagmar

机构信息

Sociedade Brasileira de Patologia Clínica/Medicina Laboratorial, Rio de Janeiro, RJ, Brazil.

Immunology Committee, Sociedade Brasileira de Patologia Clínica/Medicina Laboratorial, Rio de Janeiro, RJ, Brazil.

出版信息

Sao Paulo Med J. 2020 Jun;138(3):259-266. doi: 10.1590/1516-3180.2020.0240.14052020. Epub 2020 Jun 22.

DOI:10.1590/1516-3180.2020.0240.14052020
PMID:32578747
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9671234/
Abstract

COVID-19 (coronavirus disease 2019) is an infectious disease caused by the new coronavirus associated with severe acute respiratory syndrome 2 (SARS-CoV-2). Coronaviridae comprises a large family, of which at least seven members are known to cause respiratory diseases in humans. Coronaviruses have the ability to infect virtually all major groups of animals and, eventually, can infect humans. SARS-CoV-2 is the third coronavirus to cross the species barrier and infect humans. This virus was identified in an outbreak of pneumonia cases in Wuhan city, Hubei province, China, in December 2019. Its entire genome is inscribed on a single strand of ribonucleic acid. Some proteins present on the surface of the virus act as facilitators for its entry into host cells, while others, apparently, are related to its pathogenesis. Coronaviruses are responsible for respiratory infections in humans and some animals. The infection is often mild to moderate in intensity, but some coronaviruses may cause serious illnesses, such as severe acute respiratory syndrome (SARS), which occurred in 2002, and the Middle East respiratory syndrome (MERS). Coronaviruses can activate an excessive and unregulated immune response, which may promote SARS development. Although the lungs are one of the target organs, the hypoxia mechanism is systemic and other organs begin to suffer both through lack of oxygen and through deregulation of inflammation control mechanisms.

摘要

2019冠状病毒病(COVID-19)是一种由新型冠状病毒引起的传染病,该病毒与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)相关。冠状病毒科是一个大家族,已知其中至少有七个成员会引发人类呼吸道疾病。冠状病毒几乎能够感染所有主要动物群体,并最终感染人类。SARS-CoV-2是第三种跨越物种屏障并感染人类的冠状病毒。2019年12月,在中国湖北省武汉市爆发的肺炎病例中发现了这种病毒。其整个基因组由单链核糖核酸构成。病毒表面存在的一些蛋白质充当其进入宿主细胞的促进因子,而其他一些蛋白质显然与其发病机制有关。冠状病毒会引发人类和一些动物的呼吸道感染。感染强度通常为轻度至中度,但一些冠状病毒可能会导致严重疾病,如2002年出现的严重急性呼吸综合征(SARS)以及中东呼吸综合征(MERS)。冠状病毒可激活过度且不受控制的免疫反应,这可能会促使SARS病情发展。尽管肺部是靶器官之一,但缺氧机制是全身性的,其他器官也会因缺氧和炎症控制机制失调而开始受损。

相似文献

1
COVID-19: laboratory diagnosis for clinicians. An updating article.新型冠状病毒肺炎:临床医生的实验室诊断。一篇更新文章。
Sao Paulo Med J. 2020 Jun;138(3):259-266. doi: 10.1590/1516-3180.2020.0240.14052020. Epub 2020 Jun 22.
2
The genetic sequence, origin, and diagnosis of SARS-CoV-2.SARS-CoV-2 的基因序列、起源和诊断。
Eur J Clin Microbiol Infect Dis. 2020 Sep;39(9):1629-1635. doi: 10.1007/s10096-020-03899-4. Epub 2020 Apr 24.
3
Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征的生物学、临床和流行病学特征,以及 ACE2 的 AutoDock 模拟
Infect Dis Poverty. 2020 Jul 20;9(1):99. doi: 10.1186/s40249-020-00691-6.
4
Coronavirus Disease 2019: Coronaviruses and Blood Safety.2019 年冠状病毒病:冠状病毒与血液安全。
Transfus Med Rev. 2020 Apr;34(2):75-80. doi: 10.1016/j.tmrv.2020.02.003. Epub 2020 Feb 21.
5
[Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.].[与2019新型冠状病毒(尼多病毒目、冠状病毒科、冠状病毒亚科、β冠状病毒、Sarbecovirus亚属)相关的中国湖北省武汉市COVID-19疫情暴发的病因:严重急性呼吸综合征冠状病毒暴发的教训。]
Vopr Virusol. 2020;65(1):6-15. doi: 10.36233/0507-4088-2020-65-1-6-15.
6
The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China.致命的冠状病毒:2003 年 SARS 大流行和 2020 年中国新型冠状病毒疫情。
J Autoimmun. 2020 May;109:102434. doi: 10.1016/j.jaut.2020.102434. Epub 2020 Mar 3.
7
Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.新型冠状病毒 SARS-CoV-2、SARS-CoV 和中东呼吸综合征冠状病毒(MERS-CoV)相关病毒性肺炎的研究:文献综述。
APMIS. 2020 Jun;128(6):423-432. doi: 10.1111/apm.13047.
8
[Neurological damage linked to coronaviruses : SARS-CoV-2 and other human coronaviruses].[与冠状病毒相关的神经损伤:严重急性呼吸综合征冠状病毒2及其他人类冠状病毒]
Med Sci (Paris). 2020 Aug-Sep;36(8-9):775-782. doi: 10.1051/medsci/2020122. Epub 2020 Aug 5.
9
Coronaviruses and SARS-COV-2.冠状病毒和 SARS-COV-2。
Turk J Med Sci. 2020 Apr 21;50(SI-1):549-556. doi: 10.3906/sag-2004-127.
10
Current approaches in laboratory testing for SARS-CoV-2.目前用于 SARS-CoV-2 的实验室检测方法。
Int J Infect Dis. 2020 Nov;100:7-9. doi: 10.1016/j.ijid.2020.08.041. Epub 2020 Aug 21.

引用本文的文献

1
Relation between Orotracheal Intubation, Inflammatory Markers, Breathing and Voice in Post-COVID-19.新冠疫情后经口气管插管、炎症标志物、呼吸与嗓音之间的关系
J Voice. 2023 Feb 23. doi: 10.1016/j.jvoice.2023.02.015.
2
Pulmonary and Functional Rehabilitation Improves Functional Capacity, Pulmonary Function and Respiratory Muscle Strength in Post COVID-19 Patients: Pilot Clinical Trial.新冠后患者的肺及功能康复可改善其体能、肺功能和呼吸肌力量:一项初步临床试验。
Int J Environ Res Public Health. 2022 Nov 12;19(22):14899. doi: 10.3390/ijerph192214899.
3
Chest computed tomography in the diagnosis of COVID-19 in patients with false negative RT-PCR.胸部计算机断层扫描在 RT-PCR 假阴性 COVID-19 患者中的诊断价值。
Einstein (Sao Paulo). 2021 Nov 5;19:eAO6363. doi: 10.31744/einstein_journal/2021AO6363. eCollection 2021.
4
Demystifying Excess Immune Response in COVID-19 to Reposition an Orphan Drug for Down-Regulation of NF-κB: A Systematic Review.解析 COVID-19 过度免疫反应以重新定位孤儿药物NF-κB 下调:系统评价。
Viruses. 2021 Feb 27;13(3):378. doi: 10.3390/v13030378.
5
Laboratory diagnosis of COVID-19.新型冠状病毒肺炎的实验室诊断。
J Pediatr (Rio J). 2021 Jan-Feb;97(1):7-12. doi: 10.1016/j.jped.2020.08.001. Epub 2020 Aug 31.

本文引用的文献

1
-GlcNAc transferase promotes influenza A virus-induced cytokine storm by targeting interferon regulatory factor-5.GlcNAc 转移酶通过靶向干扰素调节因子 5 促进甲型流感病毒诱导的细胞因子风暴。
Sci Adv. 2020 Apr 15;6(16):eaaz7086. doi: 10.1126/sciadv.aaz7086. eCollection 2020 Apr.
2
Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens.SARS-CoV-2 与其他呼吸道病原体的合并感染率。
JAMA. 2020 May 26;323(20):2085-2086. doi: 10.1001/jama.2020.6266.
3
Hematological findings and complications of COVID-19.COVID-19 的血液学表现及并发症。
Am J Hematol. 2020 Jul;95(7):834-847. doi: 10.1002/ajh.25829. Epub 2020 May 23.
4
Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms.味觉和嗅觉功能障碍与以流感样症状就诊的 COVID-19 患者的关联。
Int Forum Allergy Rhinol. 2020 Jul;10(7):806-813. doi: 10.1002/alr.22579. Epub 2020 Jun 1.
5
Commentary on Ferguson, et al., "Impact of Non-pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand".评 Ferguson 等人的“减少 COVID-19 死亡率和医疗需求的非药物干预(NPIs)的影响”一文。
Bull Math Biol. 2020 Apr 8;82(4):52. doi: 10.1007/s11538-020-00726-x.
6
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.基于对来自中国武汉的150名患者数据的分析得出的COVID-19相关死亡的临床预测因素。
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
7
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病(COVID-19)疫情的特征及重要经验教训:来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
8
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
9
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
10
Pulmonary Involvement in Patients With Hemophagocytic Lymphohistiocytosis.噬血细胞性淋巴组织细胞增生症患者的肺部受累情况
Chest. 2016 May;149(5):1294-301. doi: 10.1016/j.chest.2015.11.004. Epub 2016 Jan 13.